NR1H4 and metabolic dysfunction-associated steatotic liver disease: Secondly, the pathogenesis of NAFLD by the gut-liver axis, including (#1 gut-gene interaction, #2 receptor axis, #3 human gut microbiota, #12 microbiota-conjugated bas-fxr).